Pedro A. Piedra

Affiliations: 
Baylor College of Medicine, Houston, TX 
Google:
"Pedro Piedra"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Piedra FA, Henke D, Rajan A, et al. (2023) Modeling nonsegmented negative-strand RNA virus (NNSV) transcription with ejective polymerase collisions and biased diffusion. Frontiers in Molecular Biosciences. 9: 1095193
Banerjee D, Hassan F, Avadhanula V, et al. (2022) Comparative analysis of three multiplex platforms for the detection of respiratory viral pathogens. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 156: 105274
Rajan A, Piedra FA, Aideyan L, et al. (2022) Multiple Respiratory Syncytial Virus (RSV) Strains Infecting HEp-2 and A549 Cells Reveal Cell Line-Dependent Differences in Resistance to RSV Infection. Journal of Virology. e0190421
Rajan A, Weaver AM, Aloisio GM, et al. (2022) The Human Nose Organoid Respiratory Virus Model: an Human Challenge Model To Study Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pathogenesis and Evaluate Therapeutics. Mbio. e0351121
Chen J, Qiu X, Avadhanula V, et al. (2021) Novel and extendable genotyping system for human respiratory syncytial virus based on whole-genome sequence analysis. Influenza and Other Respiratory Viruses
Doddapaneni H, Cregeen SJ, Sucgang R, et al. (2021) Oligonucleotide capture sequencing of the SARS-CoV-2 genome and subgenomic fragments from COVID-19 individuals. Plos One. 16: e0244468
Rajan A, Weaver AM, Aloisio GM, et al. (2021) The human nose organoid respiratory virus model: an ex-vivo human challenge model to study RSV and SARS-CoV-2 pathogenesis and evaluate therapeutics. Biorxiv : the Preprint Server For Biology
Ivanov V, Oomens AGP, Papin JF, et al. (2021) Intranasal and intrapulmonary vaccination with an M protein-deficient respiratory syncytial virus (RSV) vaccine improves clinical signs and reduces viral replication in infant baboons after an RSV challenge infection. Vaccine
Ye X, Iwuchukwu OP, Avadhanula V, et al. (2021) Humoral and Mucosal Antibody Response to RSV Structural Proteins in RSV-Infected Adult Hematopoietic Cell Transplant (HCT) Recipients. Viruses. 13
Dawood FS, Varner M, Munoz F, et al. (2021) Respiratory Viral Infections and Infection Prevention Practices among Women with Acute Respiratory Illness during Delivery Hospitalizations during the 2019-2020 Influenza Season. The Journal of Infectious Diseases
See more...